Kindred Biosciences akcijos akcijų analizė | Akcijų kaina | Naujienos | KIN | US4945771099 | A1XA6K

Data	Kindred Biosciences Akcijų kaina
2021-08-27	9,25 undefined
2021-08-26	9,24 undefined

Data	Kindred Biosciences Pajamos	Kindred Biosciences EBIT	Kindred Biosciences Pelnas
2024e	21,80 mln. undefined	0 undefined	0 undefined
2023e	23,54 mln. undefined	0 undefined	0 undefined
2022e	25,94 mln. undefined	0 undefined	−45,46 mln. undefined
2021e	18,08 mln. undefined	0 undefined	−45,46 mln. undefined
2020	42,16 mln. undefined	−11,90 mln. undefined	−21,80 mln. undefined
2019	4,26 mln. undefined	−62,57 mln. undefined	−61,39 mln. undefined
2018	1,97 mln. undefined	−51,26 mln. undefined	−49,69 mln. undefined
2017	0 undefined	−31,65 mln. undefined	−30,88 mln. undefined
2016	0 undefined	−22,16 mln. undefined	−22,50 mln. undefined
2015	0 undefined	−27,26 mln. undefined	−27,13 mln. undefined
2014	0 undefined	−27,23 mln. undefined	−27,14 mln. undefined
2013	0 undefined	−4,22 mln. undefined	−4,21 mln. undefined
2012	0 undefined	−120 000,00 undefined	−120 000,00 undefined

	Pajamos	EBIT	Pelnas
2012	0 USD	−120 000,00 USD	−120 000,00 USD
2013	0 USD	−4,22 mln. USD	−4,21 mln. USD
2014	0 USD	−27,23 mln. USD	−27,14 mln. USD
2015	0 USD	−27,26 mln. USD	−27,13 mln. USD
2016	0 USD	−22,16 mln. USD	−22,50 mln. USD
2017	0 USD	−31,65 mln. USD	−30,88 mln. USD
2018	1,97 mln. USD	−51,26 mln. USD	−49,69 mln. USD
2019	4,26 mln. USD	−62,57 mln. USD	−61,39 mln. USD
2020	42,16 mln. USD	−11,90 mln. USD	−21,80 mln. USD
2021e	18,08 mln. USD	0 USD	−45,46 mln. USD
2022e	25,94 mln. USD	0 USD	−45,46 mln. USD
2023e	23,54 mln. USD	0 USD	0 USD
2024e	21,80 mln. USD	0 USD	0 USD

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021e	2022e	2023e	2024e
0	0	0	0	0	0	1,00	4,00	42,00	18,00	25,00	23,00	21,00
-	-	-	-	-	-	-	300,00	950,00	−57,14	38,89	−8,00	−8,70
-	-	-	-	-	-	100,00	75,00	97,62	-	-	-	-
0	0	0	0	0	0	1,00	3,00	41,00	0	0	0	0
0	−4,00	−27,00	−27,00	−22,00	−31,00	−51,00	−62,00	−11,00	0	0	0	0
-	-	-	-	-	-	−5 100,00	−1 550,00	−26,19	-	-	-	-
0	−4,00	−27,00	−27,00	−22,00	−30,00	−49,00	−61,00	−21,00	−45,00	−45,00	0	0
-	-	575,00	-	−18,52	36,36	63,33	24,49	−65,57	114,29	-	-	-
13,30	3,73	18,78	19,77	19,87	25,08	31,00	38,66	39,29	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-

2012	2013	2014	2015	2016	2017	2018	2019	2020

0,90	65,30	101,00	73,00	56,80	81,00	73,90	71,70	58,40
0	0	0	0	0	0	900,00	900,00	600,00
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	3,60	4,20	0,20
0	0,10	0,50	0,70	1,30	0,80	1,70	2,50	3,40
0,90	65,40	101,50	73,70	58,10	81,80	80,10	79,30	62,60
0	0	0,40	1,20	2,40	7,50	26,30	32,80	31,60
0	0	0	4,60	1,10	1,50	0	1,80	1,50
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	100,00	100,00	100,00
0	0	0,40	5,80	3,50	9,00	26,40	34,70	33,20
0,90	65,40	101,90	79,50	61,60	90,80	106,50	114,00	95,80

1 000,00	0	0	0	0	0	0	0	0
0	67,60	130,50	135,00	138,80	196,70	252,90	305,00	312,30
−0,10	−4,30	−31,50	−58,60	−81,10	−112,00	−161,70	−223,10	−244,90
0	0	0	−0,10	0	0	0	0	0
0	0	0	0	0	0	0	0	0
0,90	63,30	99,00	76,30	57,70	84,70	91,20	81,90	67,40
0	0,70	0,40	0,70	0,40	1,40	3,60	1,30	0,10
0,10	1,50	2,40	2,50	3,50	4,60	11,60	9,00	5,60
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	1,10
0,10	2,20	2,80	3,20	3,90	6,00	15,20	10,30	6,80
0	0	0	0	0	0	0	19,30	18,50
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0,10	0,10	2,60	2,90
0	0	0	0	0	0,10	0,10	21,90	21,40
0,10	2,20	2,80	3,20	3,90	6,10	15,30	32,20	28,20
1,00	65,50	101,80	79,50	61,60	90,80	106,50	114,10	95,60

2012	2013	2014	2015	2016	2017	2018	2019	2020
0	−4,00	−27,00	−27,00	−22,00	−30,00	−49,00	−61,00	−21,00
0	0	0	0	0	0	0	2,00	4,00
0	0	0	0	0	0	0	0	0
0	1,00	0	0	0	3,00	−2,00	−4,00	−4,00
0	0	4,00	4,00	3,00	5,00	6,00	7,00	11,00
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0
0	−1,00	−21,00	−22,00	−18,00	−21,00	−45,00	−56,00	−9,00
0	0	0	0	0	−5,00	−13,00	−8,00	−3,00
0	0	−88,00	29,00	5,00	−2,00	16,00	−47,00	5,00
0	0	−88,00	30,00	6,00	3,00	30,00	−39,00	9,00
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	19,00	0
0	67,00	58,00	0	0	52,00	50,00	45,00	0
1,00	65,00	58,00	0	0	52,00	49,00	63,00	0
-	−1,00	-	-	-	-	-	-	-
0	0	0	0	0	0	0	0	0
0	64,00	−52,00	7,00	−13,00	28,00	21,00	−40,00	−4,00
0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0

Kindred Biosciences Bruto marža	Kindred Biosciences Pelnas-martža	Kindred Biosciences EBIT marža	Kindred Biosciences Pelnas-martža
2024e	98,10 %	0 %	0 %
2023e	98,10 %	0 %	0 %
2022e	98,10 %	0 %	−175,23 %
2021e	98,10 %	0 %	−251,39 %
2020	98,10 %	−28,23 %	−51,71 %
2019	86,15 %	−1 468,78 %	−1 441,08 %
2018	83,25 %	−2 602,03 %	−2 522,33 %
2017	98,10 %	0 %	0 %
2016	98,10 %	0 %	0 %
2015	98,10 %	0 %	0 %
2014	98,10 %	0 %	0 %
2013	98,10 %	0 %	0 %
2012	98,10 %	0 %	0 %

	Bruto marža	EBIT marža	Pelnas-martža
2012	98,10 %	0 %	0 %
2013	98,10 %	0 %	0 %
2014	98,10 %	0 %	0 %
2015	98,10 %	0 %	0 %
2016	98,10 %	0 %	0 %
2017	98,10 %	0 %	0 %
2018	83,25 %	−2 602,03 %	−2 522,33 %
2019	86,15 %	−1 468,78 %	−1 441,08 %
2020	98,10 %	−28,23 %	−51,71 %
2021e	98,10 %	0 %	−251,39 %
2022e	98,10 %	0 %	−175,23 %
2023e	98,10 %	0 %	0 %
2024e	98,10 %	0 %	0 %

Data	Kindred Biosciences Pardavimai vienai akcijai	Kindred Biosciences EBIT vienai akcijai	Kindred Biosciences Pelnas vienai akcijai
2024e	0,48 undefined	0 undefined	0 undefined
2023e	0,52 undefined	0 undefined	0 undefined
2022e	0,57 undefined	0 undefined	−1,00 undefined
2021e	0,40 undefined	0 undefined	−1,00 undefined
2020	1,07 undefined	−0,30 undefined	−0,55 undefined
2019	0,11 undefined	−1,62 undefined	−1,59 undefined
2018	0,06 undefined	−1,65 undefined	−1,60 undefined
2017	0 undefined	−1,26 undefined	−1,23 undefined
2016	0 undefined	−1,12 undefined	−1,13 undefined
2015	0 undefined	−1,38 undefined	−1,37 undefined
2014	0 undefined	−1,45 undefined	−1,45 undefined
2013	0 undefined	−1,13 undefined	−1,13 undefined
2012	0 undefined	−0,01 undefined	−0,01 undefined

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2012	0 USD	−0,01 USD	−0,01 USD
2013	0 USD	−1,13 USD	−1,13 USD
2014	0 USD	−1,45 USD	−1,45 USD
2015	0 USD	−1,38 USD	−1,37 USD
2016	0 USD	−1,12 USD	−1,13 USD
2017	0 USD	−1,26 USD	−1,23 USD
2018	0,06 USD	−1,65 USD	−1,60 USD
2019	0,11 USD	−1,62 USD	−1,59 USD
2020	1,07 USD	−0,30 USD	−0,55 USD
2021e	0,40 USD	0 USD	−1,00 USD
2022e	0,57 USD	0 USD	−1,00 USD
2023e	0,52 USD	0 USD	0 USD
2024e	0,48 USD	0 USD	0 USD

	Akcijų skaičius
2012	13,30 mln. Aktien
2013	3,73 mln. Aktien
2014	18,78 mln. Aktien
2015	19,77 mln. Aktien
2016	19,87 mln. Aktien
2017	25,08 mln. Aktien
2018	31,00 mln. Aktien
2019	38,66 mln. Aktien
2020	39,29 mln. Aktien
2021e	39,29 mln. Aktien
2022e	39,29 mln. Aktien
2023e	39,29 mln. Aktien
2024e	39,29 mln. Aktien

%	Pavadinimas	Akcijos	Pokytis	Data
8,46899 %	Point72 Asset Management, L.P.	3 850 200	3 850 200	2021-03-31
7,52585 %	Magnetar Capital Partners LP	3 421 425	3 421 425	2021-06-28
5,67437 %	Millennium Management LLC	2 579 698	2 556 576	2021-06-23
5,42957 %	BlackRock Institutional Trust Company, N.A.	2 468 407	65 659	2021-03-31
4,40556 %	The Vanguard Group, Inc.	2 002 870	19 845	2021-03-31
4,19028 %	Columbia Threadneedle Investments (UK)	1 904 998	23 304	2021-03-31
4,18428 %	Chin (Richard H)	1 902 271	−40 000	2021-07-20
3,11656 %	Renaissance Technologies LLC	1 416 859	−173 000	2021-03-31
2,58451 %	Dimensional Fund Advisors, L.P.	1 174 979	−13 906	2021-03-31
2,54974 %	Ariel Investments, LLC	1 159 169	−769 807	2021-03-31
2,03465 %	Adage Capital Management, L.P.	925 000	−750 000	2021-03-31
15,06007 %	Elanco Animal Health, Inc	6 846 657	6 846 657	2021-07-20
13,19775 %	Park West Asset Management LLC	6 000 002	−414 983	2021-07-20
1,96096 %	Bain Capital Public Equity, LP	891 500	891 500	2021-03-31
1,82795 %	Granahan Investment Management, Inc.	831 029	78 207	2021-03-31
1,53578 %	Geode Capital Management, L.L.C.	698 199	78 219	2021-03-31
1,47723 %	Acadian Asset Management LLC	671 581	217 317	2021-03-31
1,46681 %	State Street Global Advisors (US)	666 846	−47 965	2021-03-31
1,28602 %	Silverback Asset Management, LLC	584 653	−26 711	2021-03-31
1,04147 %	Allianz Global Investors GmbH	473 476	87 504	2021-03-31
0,84702 %	Victory Capital Management Inc.	385 074	−3 947	2021-03-31
0,81251 %	Wells Fargo Advisors	369 386	−3 341	2021-03-31
0,78024 %	Northern Trust Investments, Inc.	354 717	−54 915	2021-03-31
0,70617 %	Jacobs Levy Equity Management, Inc.	321 040	87 500	2021-03-31
0,69932 %	Granite Point Capital Management, L.P.	317 929	317 929	2021-03-31
0,62689 %	General American Investors Company, Inc.	285 000	−15 000	2021-03-31
0,58418 %	HealthCor Management, L.P.	265 580	265 580	2021-03-31
0,44212 %	DCF Advisers, LLC	201 000	161 000	2021-03-31
0,41993 %	Two Sigma Investments, LP	190 908	146 216	2021-03-31
0,34031 %	Nuveen LLC	154 713	−4 021	2021-03-31
0,32078 %	Bevers (Denise M.)	145 835	0	2021-07-20
0,31895 %	BCK Capital Management LP	145 000	145 000	2021-06-30
0,31436 %	BlackRock Investment Management, LLC	142 915	3 575	2021-03-31
0,30795 %	Independent Securities (Pty) Ltd	140 000	0	2021-05-31
0,29145 %	Gabelli Funds, LLC	132 500	32 500	2021-03-31
0,28362 %	Goldman Sachs & Company, Inc.	128 942	7 952	2021-03-31
0,27914 %	Squarepoint Capital LLP	126 905	111 172	2021-03-31
0,27403 %	New York State Common Retirement Fund	124 582	26 900	2021-03-31
0,23185 %	J.P. Morgan Securities LLC	105 406	11 014	2021-03-31
0,21210 %	Charles Schwab Investment Management, Inc.	96 426	0	2021-03-31
0,20955 %	BlackRock Financial Management, Inc.	95 265	−9 998	2021-03-31
0,20882 %	Columbia Threadneedle Investments (US)	94 936	−9 528	2021-03-31
0,19676 %	BNY Mellon Asset Management	89 450	−464	2021-03-31
0,18188 %	UBS Financial Services, Inc.	82 685	7 149	2021-03-31
0,17524 %	Morgan Stanley & Co. LLC	79 670	−93 283	2021-03-31
0,16761 %	QS Investors, LLC	76 200	76 200	2021-03-31
0,16673 %	California Public Employees' Retirement System	75 800	0	2021-03-31
0,16497 %	Harvest Management, LLC	75 000	75 000	2021-06-30
0,15255 %	Los Angeles Capital Management And Equity Research, Inc.	69 353	−1 600	2021-03-31
0,14502 %	Russell Investments Trust Company	65 930	65 528	2021-03-31
0,14091 %	Citadel Advisors LLC	64 063	12 164	2021-03-31
0,13792 %	Osborn Williams & Donohoe LLC	62 700	0	2020-03-31
0,13792 %	Hightower Advisors, LLC	62 700	0	2021-03-31
0,13527 %	Goldman Sachs Asset Management, L.P.	61 496	48 297	2021-03-31
0,12357 %	California State Teachers Retirement System	56 177	−1 512	2021-03-31
0,11227 %	Wee (Wendy K)	51 039	2 000	2021-07-20
0,10290 %	Rhumbline Advisers Ltd. Partnership	46 782	−1 870	2021-03-31
0,09436 %	AllianceBernstein L.P.	42 900	0	2021-03-31
0,09269 %	Northern Trust Global Investments	42 140	29	2021-03-31
0,09184 %	PDT Partners, LLC	41 753	7 653	2021-03-31
0,08646 %	Zhan (Hangjun)	39 306	0	2021-07-20
0,07837 %	CIM Investment Management Inc.	35 630	−2 124	2021-03-31
0,07510 %	Mellon Investments Corporation	34 141	0	2021-03-31
0,07473 %	BofA Global Research (US)	33 975	16 126	2021-03-31
0,07446 %	Susquehanna International Group, LLP	33 849	−40 259	2021-03-31
0,07039 %	New Jersey Division of Investment	32 000	0	2021-06-30
0,06851 %	Barclays Bank PLC	31 146	19 119	2021-03-31
0,06599 %	Edgewood Management LLC	30 000	0	2021-03-31
0,06582 %	Group One Trading, L.P.	29 924	29 924	2021-03-31
0,05863 %	Parametric Portfolio Associates LLC	26 655	752	2021-03-31
0,05719 %	Teton Advisors, Inc.	26 000	0	2021-03-31
0,05518 %	Ohio Public Employees Retirement System	25 088	12 858	2021-03-31
0,05483 %	Townsend (Raymond J)	24 928	0	2021-07-20
0,05319 %	DWS Investments UK Limited	24 182	−2 262	2021-03-31
0,05162 %	Dimensional Fund Advisors, Ltd.	23 468	0	2021-04-30
0,04776 %	SunAmerica Asset Management, LLC	21 713	57	2021-03-31
0,04762 %	Sit Investment Associates, Inc.	21 650	0	2021-03-31
0,04751 %	Deutsche Asset Management Americas	21 600	0	2021-03-31
0,04328 %	Advisor Group, Inc	19 675	12 575	2021-03-31
0,04321 %	Wells Fargo Bank, N.A.	19 643	−43 868	2021-03-31
0,04308 %	Wells Capital Management Inc.	19 585	−10 215	2021-03-31
0,04161 %	Manulife Investment Management (North America) Limited	18 915	−7 781	2021-03-31
0,04039 %	Voya Investment Management LLC	18 360	2 474	2021-03-31
0,03905 %	Eagle Asset Management, Inc.	17 753	17 753	2020-03-31
0,03647 %	Hancock Horizon Investments	16 580	0	2021-03-31
0,03639 %	Evanson Asset Management, LLC	16 545	0	2021-06-30
0,03377 %	AXA Rosenberg Investment Management LLC	15 351	0	2021-05-31
0,03145 %	Leap Investments LP	14 300	14 300	2020-06-30
0,03073 %	JPMorgan Private Bank (United States)	13 970	−2 525	2021-03-31
0,02749 %	Florida State Board of Administration	12 497	0	2021-03-31
0,02505 %	Water Island Capital, LLC	11 387	11 387	2021-06-30
0,02310 %	Stifel Nicolaus Investment Advisors	10 500	10 500	2021-03-31
0,01999 %	H. M. Payson & Co.	9 090	9 090	2021-03-31
0,01738 %	Cubist Systematic Strategies, LLC	7 903	7 903	2021-03-31
0,01703 %	Mackenzie Financial Corporation	7 744	−1 079	2021-03-31
0,01566 %	BNY Mellon Wealth Management	7 120	345	2021-03-31
0,01428 %	BlackRock Investment Management (UK) Ltd.	6 494	−16 279	2021-03-31
0,01386 %	Park Circle Company	6 300	0	2021-03-31
0,01138 %	BNP Paribas Securities Corp. North America	5 173	−4 235	2021-03-31
0,01106 %	PanAgora Asset Management Inc.	5 027	5 027	2021-03-31

What values and corporate philosophy does Kindred Biosciences represent?

Kindred Biosciences Inc represents a strong commitment to improving the lives of animals through innovative veterinary biologics and therapeutics. The company values include integrity, innovation, collaboration, and a dedication to scientific excellence. Kindred Biosciences is driven by a corporate philosophy that emphasizes the importance of research and development, aiming to address unmet veterinary needs and provide effective treatments for various animal species. By leveraging cutting-edge technologies and partnerships, Kindred Biosciences strives to make a positive impact on animal health, while also creating value for its shareholders.

In which countries and regions is Kindred Biosciences primarily present?

Kindred Biosciences Inc primarily operates in the United States.

What significant milestones has the company Kindred Biosciences achieved?

Since its establishment, Kindred Biosciences Inc has accomplished several significant milestones. The company successfully received approval from the Food and Drug Administration (FDA) for their groundbreaking therapies, such as Zimeta, Mirataz, and KIND-016. Additionally, Kindred Biosciences Inc has entered into strategic partnerships and collaborations with renowned pharmaceutical companies, enabling them to expand their research and development capabilities. These partnerships have played a pivotal role in advancing the company's pipeline, leading to the development of innovative treatments for various animal diseases. Kindred Biosciences Inc continues to exhibit strong commitment towards improving animal health and welfare through their pioneering achievements and ongoing efforts.

What is the history and background of the company Kindred Biosciences?

Kindred Biosciences Inc, a biopharmaceutical company, has a fascinating history and background. It was founded in 2012 and is headquartered in California, United States. The company specializes in developing innovative medicines for veterinary use. Kindred Biosciences is committed to enhancing the lives of pets by focusing on unmet medical needs. With a highly experienced team and state-of-the-art facilities, they strive to develop effective therapies and treatments for various animal diseases. Kindred Biosciences has gained recognition for its dedication to animal health and its successful development of novel biologics. Continuously expanding its product portfolio, the company seeks to revolutionize veterinary medicine.

Who are the main competitors of Kindred Biosciences in the market?

The main competitors of Kindred Biosciences Inc in the market are Zoetis Inc., Elanco Animal Health Inc., and IDEXX Laboratories Inc.

In which industries is Kindred Biosciences primarily active?

Kindred Biosciences Inc is primarily active in the biotechnology and pharmaceutical industries.

What is the business model of Kindred Biosciences?

The business model of Kindred Biosciences Inc, a biopharmaceutical company, focuses on veterinary medicine. They develop innovative therapeutics for animals, aiming to improve the lives of pets and horses. Kindred Biosciences creates drugs for various conditions that affect animals, including allergies, infections, and gastrointestinal disorders. Their mission is to provide effective and safe medications to improve the well-being of companion animals. With a strong commitment to research and development, Kindred Biosciences pioneers advancements in animal healthcare, seeking to address unmet medical needs in the veterinary industry and contribute to the overall betterment of animal health.

Koks yra Kindred Biosciences 2024 KGV?

Kindred Biosciences KGV yra 0.

Koks Kindred Biosciences 2024 KUV?

Kindred Biosciences KUV yra 16,67.

Koks yra Kindred Biosciences AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis Kindred Biosciences yra 1/10.

Koks yra Kindred Biosciences 2024 pajamų dydis?

tikėtina Kindred Biosciences pardavimai yra 21,80 mln. USD.

Kokia yra Kindred Biosciences 2024 pelnas?

Pelnas šiuo metu negali būti apskaičiuotas Kindred Biosciences.

Ką daro Kindred Biosciences?

Kindred Biosciences Inc. is a biopharmaceutical company focused on the development of innovative animal health products. The company aims to improve animal lives and provide pet owners with innovative and effective therapies. It is divided into three main business areas: Biologics, small molecules, and diagnostics. In the field of Biologics, Kindred Biosciences develops innovative biopharmaceutical products for animals. The focus is on researching and developing antibodies and proteins that block or neutralize disease-causing target molecules. Examples include Zimeta, an injectable medication for treating fever in horses, and KIND-010, an antibody for treating atopic dermatitis in dogs. The small molecules division focuses on developing chemical compounds for treating diseases in animals. Kindred Biosciences uses its own technology platform to identify and optimize molecules that bind to specific target molecules in the body. An example is Mirataz, a topical gel for treating cats with compulsive disorders. The diagnostics division offers a wide range of tests and instruments for the rapid and reliable diagnosis of animal diseases. For example, the SUCCEED Equine Fecal Blood Test measures the worm burden in horses, allowing for targeted deworming. Kindred Biosciences also conducts extensive research and development to continuously expand and improve its portfolio of animal health products. The company collaborates closely with the veterinary community and utilizes advanced technologies and methods such as protein engineering and CRISPR/Cas9 to explore new therapeutic approaches. Overall, Kindred Biosciences offers a broad range of animal health products valued by both veterinarians and pet owners. The company stands out for its strong research and development efforts, close collaboration with the veterinary community, and innovative technologies. With a strong market position and solid growth strategy, Kindred Biosciences is an important player in the animal health products market.

Kokia yra Kindred Biosciences dividendė?

Kindred Biosciences moka dividendą 0 USD, kuris yra paskirstytas per išmokas per metus.

Kiek kartų Kindred Biosciences moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota Kindred Biosciences arba įmonė dividendų nemoka.

Kas yra Kindred Biosciences ISIN?

Kindred Biosciences ISIN yra US4945771099.

Kas yra Kindred Biosciences WKN?

Kindred Biosciences WKN yra A1XA6K.

Kas yra Kindred Biosciences Tickeris?

Kindred Biosciences akcijų simbolis yra KIN.

Kiek dividendų moka Kindred Biosciences?

Per paskutinius 12 mėnesių Kindred Biosciences išmokėjo dividendą, kurios dydis siekė . Tai atitinka maždaug dividendų grąžą. Artimiausiems 12 mėnesiams Kindred Biosciences tikėtina išmokės dividendus, kurie sudarys 0 USD.

Kokia yra Kindred Biosciences dividendų grąža?

Kindred Biosciences šiuo metu yra dydžio dividendų grąža.

Kada Kindred Biosciences moka dividendus?

Kindred Biosciences moka dividendus kas ketvirtį. Jie išmokami mėnesiais.

Kokia saugi yra Kindred Biosciences dividendų išmokėjimas?

Kindred Biosciences per paskutiniuosius 0 metus kiekvienais metais mokėjo dividendus.

Kokia yra Kindred Biosciences dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0 USD. Tai atitinka 0 % dividendų grąžos procentą.

Kokiame sektoriuje yra Kindred Biosciences?

Kindred Biosciences priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von Kindred Biosciences kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį Kindred Biosciences dividendą nuo 2024-09-18, kurio dydis yra 0 USD, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-09-18.

Kada Kindred Biosciences paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-09-18.

Kokia buvo Kindred Biosciences dividendų suma 2023 metais?

2023 metais Kindred Biosciences išmokėjo 0 USD dividendų.

Kokia valiuta Kindred Biosciences moka dividendus?

Kindred Biosciences dividendai yra mokami USD.

Kindred Biosciences Akcijų kodas	Kindred Biosciences FIGI
KIN1USD:XB	BBG00JQ257S4
KIN1USD:XS	BBG00JQ25875

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodasKIN

ISINUS4945771099

VVPA1XA6K

Kindred Biosciences akcijų kaina

Kursas

Apžvalga

Intraday funkcija

Bendroji grąža ir santykinė kainų pokyčiai

Interpretacija ir investavimas

Kindred Biosciences Akcijų istorija

Kindred Biosciences akcijų apyvarta, EBIT, pelnas US4945771099 · A1XA6K

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

Kindred Biosciences Pajamų, pelno ir EBIT istorija.

Kindred Biosciences Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

Kindred Biosciences Akcijos Maržos US4945771099 · A1XA6K

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

Kindred Biosciences Maržų istorija

Kindred Biosciences akcijos apyvarta, EBIT, pelnas vienai akcijai US4945771099 · A1XA6K

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Kindred Biosciences Pardavimų, pelno ir EBIT istorija vienai akcijai

Kindred Biosciences akcija ir akcijų analizė

Kindred Biosciences vertinimas pagal Fair Value

Fair Value

Supratimas apie Fair Value

Pajamų pagrindu skaičiuojamas Fair Value

Apyvartos pagrindu skaičiuojamas Fair Value

Dividendų pagrindu skaičiuojamas Fair Value

Lūkesčiai ir prognozės

Palyginamoji analizė

Kindred Biosciences įvertinimas pagal istorinį P/E, EBIT ir P/S

Kindred Biosciences akcijų skaičius US4945771099 · A1XA6K

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Kindred Biosciences Pelno prognozės

Kindred Biosciences Pelnų staigmenos

Kindred Biosciences akcijos akcininkų struktūra

Dažnai užduodami klausimai apie Kindred Biosciences akciją

What values and corporate philosophy does Kindred Biosciences represent?

In which countries and regions is Kindred Biosciences primarily present?

What significant milestones has the company Kindred Biosciences achieved?

What is the history and background of the company Kindred Biosciences?

Who are the main competitors of Kindred Biosciences in the market?

In which industries is Kindred Biosciences primarily active?

What is the business model of Kindred Biosciences?

Koks yra Kindred Biosciences 2024 KGV?

Koks Kindred Biosciences 2024 KUV?

Padaryk geriausias savo gyvenimo investicijas
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Akcijų kodas
KIN

ISIN
US4945771099

VVP
A1XA6K